Search

everythinglearnresearchcommunity

for

Search:↓

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

CDKN2AIP gene is less active in nevus sebaceous, affecting related RNA networks.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

NXC736 significantly reduced hair loss in mice with alopecia areata.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Higher levels of certain immune cells in hair follicles may contribute to alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata.

IL-18 signaling helps mature Tregs move into the thymus.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

People with acne have more CD4+ immune cells in their skin than healthy people.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

B cells can both help and hinder the body's defense against melanoma.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

CD200 is not a reliable marker for identifying stem cells in all skin types.

Innate lymphoid cells type 1 may contribute to alopecia areata.

CD34 is a marker for isolating stem-like cells in mouse hair follicles.

CMV infection increases the risk of GvHD after bone marrow transplants.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Blocking certain proteins on immune cells may help treat alopecia areata.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Reduced CD44 expression may cause abnormal hyaluronate buildup in cutaneous myxoma.